Has Meranda Mayer received payments from drug or device companies?

Yes. Drug and device makers reported $2,047 in general payments to Meranda Mayer across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Meranda Mayer did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Meranda Mayer come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Meranda Mayer

Physician Assistant · New Brunswick, NJNPI 1467143636

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations.

$2,047in general payments, 2019–2025

Across 101 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Galderma Laboratories, L.p.$375
Incyte Corporation$321
Sun Pharmaceutical Industries Inc.$218
AbbVie$202
Novartis$170
Regeneron Healthcare Solutions, Inc.$116
plus $644 from 14 others

What the payments were for

Food & beverage$2,047100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Galderma Laboratories, L.p.	20	$375
Incyte Corporation	8	$321
Sun Pharmaceutical Industries Inc.	7	$218
AbbVie	16	$202
Novartis	5	$170
Regeneron Healthcare Solutions, Inc.	7	$116
Ortho Dermatologics, A Division Of Bausch Health US, LLC	6	$105
Lilly USA, LLC	4	$78
UCB, Inc.	4	$70
Mayne Pharma Commercial LLC	6	$64
Amgen	3	$56
Johnson & Johnson	3	$52
Journey Medical Corporation	2	$42
LEO Pharma Inc.	2	$35
Almirall LLC	2	$33
Arcutis Biotherapeutics, Inc.	2	$32
Kerecis Limited	1	$22
Biofrontera Inc.	1	$20
Organon	1	$18
Dermavant Sciences, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,047 in reported general payments places this provider in the 85th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey →

Other physician assistant in New Brunswick

Alexa HetzelEast Windsor$588K
Nicole Schmid DavisHamilton$148K
Todd NewmanHoboken$73K
Patrick McGinnShrewsbury$72K
Tatiana Dell'aquilaNutley$43K
Nicole ColucciRiverdale$36K
Salvatore SciurbaMiddletown$25K
Jacqueline CristiniEdison$22K
Mark MazakLakewood$21K
Andrea BarkerPrinceton$21K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →